ArticleThe Lancet. Infectious diseases2024

The Dengue-in-Dhaka Initiative: results from a phase 2 trial evaluating the TV005 tetravalent dengue vaccine in Bangladesh.

Annelies Wilder-SmithPubMed ↗Publisher ↗

No numbers read from the abstract.